Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Luminal Breast Cancer Cryoablation

NCT: NCT07447414 · RECRUITING

NCT IDNCT07447414
StatusRECRUITING
Start Date2026-04-08
Completion2028-12

Brief Summary

LUBRECA will evaluate the safety and efficacy of cryoablation with liquid nitrogen to treat cT1cN0 luminal breast cancer diagnosed in postmenopausal women

Frequently Asked Questions

What is Luminal Breast Cancer Cryoablation?

Luminal Breast Cancer Cryoablation is a clinical trial registered under NCT07447414. Current status: RECRUITING.

What is the status of NCT07447414?

The current status of NCT07447414 (Luminal Breast Cancer Cryoablation) is: RECRUITING.

When did Luminal Breast Cancer Cryoablation start?

Luminal Breast Cancer Cryoablation started on 2026-04-08.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑